Spencer Hansen, MD
Vascular Surgery · Loveland, CONPI 1861832255
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (40.0%), grants and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 86.6% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2024 at $9,805 and has fallen 88.0% since, to $1,175 in 2025.
Across 108 payments — averaging $198.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$19K
- Endologix LLC$499
- Bolton Medical Inc$485
- W. L. Gore & Associates, Inc.$444
- Angiodynamics, Inc.$318
- Silk Road Medical, Inc.$209
- plus $915 from 12 others
What the payments were for
- Grants$6,67231%
- Travel & lodging$8,58340%
- Food & beverage$6,19929%
- Education$20%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 61 | $18,586 |
| Endologix LLC | 7 | $499 |
| Bolton Medical Inc | 6 | $485 |
| W. L. Gore & Associates, Inc. | 4 | $444 |
| Angiodynamics, Inc. | 9 | $318 |
| Silk Road Medical, Inc. | 2 | $209 |
| Bard Peripheral Vascular, Inc. | 3 | $201 |
| Boston Scientific | 2 | $174 |
| Cook Medical LLC | 1 | $172 |
| Penumbra, Inc. | 1 | $150 |
| Mallinckrodt Enterprises LLC | 3 | $52 |
| Pfizer | 3 | $39 |
| Shockwave Medical, Inc | 1 | $33 |
| Route 92 Medical, Inc. | 1 | $30 |
| Smith+Nephew | 1 | $18 |
| Terumo Medical Corporation | 1 | $17 |
| Mallinckrodt Hospital Products Inc. | 1 | $14 |
| Getinge USA Sales, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENDURANT IIS$9,075
- Endurant$8,300
- TREO ABDOMINAL STENT-GRAFT SYSTEM$293
- ENROUTE Transcarotid Stent$176
- ENROUTE Transcarotid Neuroprotection System$176
- GORE TAG Conformable Thoracic Endoprosthesis$169
- EKOSONIC$153
- Penumbra System$150
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$138
- AFX2 Bifurcated Endograft System$127
- Aptus Heli-FX$125
- COVERA$123
- HawkOne$118
- GORE TAG Thoracic Branch Endoprosthesis$101
- ENDOCROSS Device$100
- Torus Stent Graft System$100
How this compares
$21,456 in reported general payments places this provider in the 80th percentile of 66 vascular surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 19 | $18,567 |
| ClopidogrelClopidogrel Bisulfate | 52 | $502 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 41 | $210 |
| Atorvastatin Calcium | 14 | $150 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $39 | $18,56719 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 66 vascular surgery providers in Colorado.
Other vascular surgery in Loveland
- Peter LaymanLoveland$10K
- Richard DenneyLoveland$3K
- Rafael MalgorAurora$263K
- Brandon Roy-GarlandDenver$190K
- Donald JacobsAurora$126K
- Srikant SivaramanEnglewood$70K
- Melhem SharafuddinColorado Springs$46K
- Emily MalgorAurora$39K
- Jeniann YiAurora$34K
- Lisa BennettDenver$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.